NCT02047565 A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation Status COMPLETED Phase PHASE1
NCT02039726 (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive Status COMPLETED Phase PHASE3
NCT02004678 Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01973569 AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment Status COMPLETED Phase NA
NCT01957280 Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287) Status COMPLETED Phase PHASE1
NCT01956305 Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study Status COMPLETED Phase PHASE1
NCT01877382 A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT01862939 A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01826448 A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma Status TERMINATED Phase PHASE1
NCT01794000 A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Status TERMINATED Phase PHASE3
NCT01790503 A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01765400 Platelet Inhibition in Patients With Systolic Heart Failure Status COMPLETED Phase PHASE4
NCT01756898 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01755767 Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy Status COMPLETED Phase PHASE3
NCT01740037 IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4 Status COMPLETED Phase NA
NCT01699061 Effect of Tivantinib on the QTC Interval in Cancer Subjects Status COMPLETED Phase PHASE1
NCT01662908 A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis Status COMPLETED Phase PHASE2